Richard Malamut
Chief Tech/Sci/R&D Officer presso MEDINCELL S.A.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Richard Malamut is currently the Director at Chromocell Therapeutics Corp.
and the Chief Medical Officer at MedinCell SA. Previously, he held positions as the Vice President-Global Clinical Development at Teva Pharmaceutical Industries Ltd.
from 2013 to 2016, the Chief Medical Officer at Avanir Pharmaceuticals, Inc., the Chief Medical Officer & Executive Vice President at Collegium Pharmaceutical, Inc. from 2019 to 2022, and the Chief Medical Officer & Senior Vice President at Braeburn, Inc. from 2018 to 2019.
He obtained his doctorate degree from Hahnemann University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 16/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Richard Malamut
| Società | Posizione | Inizio |
|---|---|---|
| MEDINCELL S.A. | Chief Tech/Sci/R&D Officer | 09/05/2022 |
| CHROMOCELL THERAPEUTICS CORPORATION | Director/Board Member | 01/01/2023 |
Precedenti posizioni note di Richard Malamut
| Società | Posizione | Fine |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Chief Tech/Sci/R&D Officer | 23/03/2022 |
| BRAEBURN INC. | Chief Tech/Sci/R&D Officer | 01/01/2019 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/11/2016 |
| AVANIR PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | - |
Formazione di Richard Malamut
| Hahnemann University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| MEDINCELL S.A. | Health Technology |
| CHROMOCELL THERAPEUTICS CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Braeburn, Inc.
 Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Braeburn, Inc. manufactures pharmaceutical products. It focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain and schizophrenia. The firm develops Probuphine for the treatment of adult patients with opioid dependence. The company was founded in 2012 and is headquartered in Princeton, NJ. | Commercial Services |
- Borsa valori
- Insiders
- Richard Malamut
